MGRX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Mangoceuticals Inc (MGRX) is not a good buy at this moment for a beginner, long-term investor with $50,000-$100,000 available for investment. The stock lacks strong positive catalysts, has weak financial performance, and no significant trading signals or sentiment to support an immediate purchase. The technical indicators and recent trends suggest a lack of upward momentum, and the company's financials show declining revenue and profitability. Given the user's impatience and preference for long-term investments, this stock does not align with their goals.
The MACD is slightly positive, indicating weak bullish momentum, but the RSI is neutral at 55.322. Moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the stock is trading below key resistance levels (R1: 0.401). The pre-market price is $0.3595, down -2.84%, showing weakness. Overall, the technical indicators do not support a strong buy signal.
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
Declining revenue (-36.83% YoY), negative EPS (-0.69, down -95.35% YoY), and weak gross margin (-2.53% YoY). The stock also has a 60% chance of declining -2.36% in the next week and -18.83% in the next month.
In Q3 2025, revenue dropped to $84,246 (-36.83% YoY), net income improved to -$7,912,218 (+295.76% YoY), but EPS fell to -0.69 (-95.35% YoY). Gross margin also declined slightly to 60.42% (-2.53% YoY). Overall, the financial performance is weak, with declining revenue and profitability metrics.
No analyst rating or price target changes available.
